Olema Pharmaceuticals Overview
Olema Pharmaceuticals Target Price
Analysts' 12-month price predictions for OLMA.
Get informed when a big investor buys or sells
+ FollowShare Price
$10.68
Average Target Price
$40.33
277.7% upside
277.7% upside3 analysts in the last 4 months
High: $48 | Low: $35
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-13 | Guggenheim | $35 | 227.7% upside |  |
| 2026-03-09 | H.C. WainwrightEmily Bodnar | $38 | 255.8% upside | |
| 2026-02-10 | Stifel Nicolaus | $48 | 349.4% upside | |
| 2026-01-07 | Piper Sandler | $40 | 274.5% upside | |
| 2026-01-07 | UBSMichael Yee | $45 | 321.3% upside | |
| 2025-12-11 | Oppenheimer | $48 | 349.4% upside | |
| 2025-12-11 | Goldman Sachs | $38 | 255.8% upside | |
| 2025-12-11 | H.C. WainwrightEmily Bodnar | $45 | 321.3% upside | |
| 2025-12-10 | JefferiesMichael Yee | $43 | 302.6% upside | |
| 2025-11-21 | Goldman Sachs | $26 | 143.4% upside | |
| 2025-11-20 | Guggenheim | $40 | 274.5% upside | |
| 2025-11-18 | H.C. Wainwright | $36 | 237.1% upside | |
| 2025-10-20 | H.C. WainwrightEmily Bodnar | $28 | 162.2% upside | |
| 2025-10-08 | Guggenheim | $20 | 87.3% upside | |
| 2024-10-24 | Goldman SachsRichard Law | $27 | 152.8% upside | |
| 2024-05-16 | H.C. WainwrightEmily Bodnar | $30 | 180.9% upside | |
| 2024-04-02 | Goldman SachsRichard Law | $24 | 124.7% upside | |